These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6717889)

  • 21. Phase II double-blind randomized study of lonidamine and radiotherapy in epidermoid carcinoma of the lung.
    Privitera G; Ciottoli GB; Patanè C; Palmucci T; Tafuri G; Marletta F; De Luca B; Magnani F; De Gregorio M; Greco S
    Radiother Oncol; 1987 Dec; 10(4):285-90. PubMed ID: 3444905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential antitumor agents, XIII. Indole derivatives related to lonidamine.
    Andreani A; Rambaldi M; Bonazzi D; Andreani F; Bossa R; Galatulas I
    Arch Pharm (Weinheim); 1984 Oct; 317(10):847-51. PubMed ID: 6517671
    [No Abstract]   [Full Text] [Related]  

  • 23. Phase I and clinical pharmacologic evaluation of Lonidamine in patients with advanced cancer.
    Young CW; Currie VE; Kim JH; O'Hehir MA; Farag FM; Kinahan JE
    Oncology; 1984; 41 Suppl 1():60-5. PubMed ID: 6717897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
    Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
    Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer.
    Altundag O; Altundag K; Morandi P; Hanrahan E
    Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617
    [No Abstract]   [Full Text] [Related]  

  • 26. Head and neck cancers: making headway in their treatment?
    McCann J
    J Natl Cancer Inst; 2000 Jan; 92(1):11-3. PubMed ID: 10620623
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined treatment techniques in head and neck cancer: radiation therapy, chemotherapy and hyperthermia.
    Brady LW
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):68-74. PubMed ID: 619215
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II evaluation of Lonidamine in patients with advanced malignancy.
    Evans WK; Shepherd FA; Mullis B
    Oncology; 1984; 41 Suppl 1():69-77. PubMed ID: 6717899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lonidamine: a hyperthermic sensitizer of HeLa cells in culture and of the Meth-A tumor in vivo.
    Kim JH; Kim SH; Alfieri A; Young CW; Silvestrini B
    Oncology; 1984; 41 Suppl 1():30-5. PubMed ID: 6717892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of Lonidamine in cancer patients.
    Band PR; Deschamps M; Besner JG; Leclaire R; Gervais P; De Sanctis A
    Oncology; 1984; 41 Suppl 1():66-8. PubMed ID: 6717898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of lonidamine in metastatic breast cancer.
    Pronzato P; Amoroso D; Bertelli G; Conte PF; Cusimano MP; Ciottoli GB; Gulisano M; Lionetto R; Rosso R
    Br J Cancer; 1989 Feb; 59(2):251-3. PubMed ID: 2930690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Weinerman BH; Eisenhauer EA; Besner JG; Coppin CM; Stewart D; Band PR
    Cancer Treat Rep; 1986 Jun; 70(6):751-4. PubMed ID: 3524824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
    Silvestrini B; Hahn GM; Cioli V; De Martino C
    Br J Cancer; 1983 Feb; 47(2):221-31. PubMed ID: 6824568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiotherapy and chemotherapy in treatment of head and neck cancer.
    Dalley VM
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):173-9. PubMed ID: 75876
    [No Abstract]   [Full Text] [Related]  

  • 35. Lonidamine in the treatment of chronic lymphoid leukemia.
    Tura S; Cavo M; Gobbi M; Franchi P
    Oncology; 1984; 41 Suppl 1():90-3. PubMed ID: 6717903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Docetaxel: a new weapon in the treatment of head and neck tumors].
    Melano M
    Tumori; 2001; 87(6):A9-10. PubMed ID: 11995709
    [No Abstract]   [Full Text] [Related]  

  • 37. Lonidamine plus adriamycin versus adriamycin alone in the adjuvant treatment of recurrent papillary carcinomas of the urinary bladder.
    Giannotti P; Ambrogi F; Ciottoli GB
    Oncology; 1984; 41 Suppl 1():104-7. PubMed ID: 6717888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taxol plus radiation for head and neck cancer.
    Rosenthal DI; Carbone DP
    J Infus Chemother; 1995; 5(2):46-54. PubMed ID: 8521234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of lonidamine in patients with small cell carcinoma of the lung.
    Murray N; Shah A; Band P
    Cancer Treat Rep; 1987 Dec; 71(12):1283-4. PubMed ID: 2825992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in radiation therapy of head and neck cancer.
    Popovtzer A; Eisbruch A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):633-44. PubMed ID: 18402530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.